APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Formulary Management

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drug Formulary Management Market Outlook and Growth Opportunities 2026

6 March 2026196 pages

Choose your research edition.

Industry ResearchDrug Formulary Management Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Formulary Management Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Drug Formulary Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Formulary Management Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Formulary Management Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Drug Formulary Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drug Formulary Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Formulary Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Formulary Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drug Formulary Management market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drug Formulary Management market include First Databank, Evernorth Health, Wolters Kluwer, McKesson, Salesforce, Pharmacy Purchasing & Products, VativoRx, Nuwae and MedReb8, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Drug Formulary Management market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Formulary Management and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Formulary Management revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug Formulary Management market.

Drug Formulary Management Segment by Company

First Databank

Evernorth Health

Wolters Kluwer

McKesson

Salesforce

Pharmacy Purchasing & Products

VativoRx

Nuwae

MedReb8

Drug Formulary Management Segment by Type

Open Formulary

Closed Formulary

Drug Formulary Management Segment by Application

Hospital

Managed Care Organization (MCO)

Others

Drug Formulary Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drug Formulary Management status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Drug Formulary Management key companies, revenue, market share, and recent developments.

3. To split the Drug Formulary Management breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Drug Formulary Management market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drug Formulary Management significant trends, drivers, influence factors in global and regions.

6. To analyze Drug Formulary Management competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Formulary Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Formulary Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Formulary Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Formulary Management industry.

Chapter 3: Detailed analysis of Drug Formulary Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Drug Formulary Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Drug Formulary Management in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drug Formulary Management Industry Trends Table 2. Drug Formulary Management Industry Drivers Table 3. Drug Formulary Management Industry Opportunities and Challenges Table 4. Drug Formulary Management Industry Restraints Table 5. Global Drug Formulary Management Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drug Formulary Management Revenue Share by Company (2021-2026) Table 7. Global Drug Formulary Management Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Drug Formulary Management Key Company Manufacturing Base & Headquarters Table 9. Global Drug Formulary Management Company, Product Type & Application Table 10. Global Drug Formulary Management Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Drug Formulary Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Open Formulary Table 15. Significant Companies of Closed Formulary Table 16. Global Drug Formulary Management Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Drug Formulary Management Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Drug Formulary Management Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Drug Formulary Management Sales Value Share by Type (2021-2026) Table 20. Global Drug Formulary Management Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Managed Care Organization (MCO) Table 23. Significant Companies of Others Table 24. Global Drug Formulary Management Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Drug Formulary Management Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Drug Formulary Management Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Drug Formulary Management Sales Value Share by Application (2021-2026) Table 28. Global Drug Formulary Management Sales Value Share by Application (2027-2032) Table 29. Global Drug Formulary Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Drug Formulary Management Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Drug Formulary Management Sales Value Share by Region (2021-2026) Table 32. Global Drug Formulary Management Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Drug Formulary Management Sales Value Share by Region (2027-2032) Table 34. Global Drug Formulary Management Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Drug Formulary Management Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Drug Formulary Management Sales Value Market Share by Country (2021-2026) Table 37. Global Drug Formulary Management Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Drug Formulary Management Sales Value Market Share by Country (2027-2032) Table 39. First Databank Company Information Table 40. First Databank Business Overview Table 41. First Databank Drug Formulary Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. First Databank Drug Formulary Management Product Portfolio Table 43. First Databank Recent Development Table 44. Evernorth Health Company Information Table 45. Evernorth Health Business Overview Table 46. Evernorth Health Drug Formulary Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Evernorth Health Drug Formulary Management Product Portfolio Table 48. Evernorth Health Recent Development Table 49. Wolters Kluwer Company Information Table 50. Wolters Kluwer Business Overview Table 51. Wolters Kluwer Drug Formulary Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Wolters Kluwer Drug Formulary Management Product Portfolio Table 53. Wolters Kluwer Recent Development Table 54. McKesson Company Information Table 55. McKesson Business Overview Table 56. McKesson Drug Formulary Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. McKesson Drug Formulary Management Product Portfolio Table 58. McKesson Recent Development Table 59. Salesforce Company Information Table 60. Salesforce Business Overview Table 61. Salesforce Drug Formulary Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Salesforce Drug Formulary Management Product Portfolio Table 63. Salesforce Recent Development Table 64. Pharmacy Purchasing & Products Company Information Table 65. Pharmacy Purchasing & Products Business Overview Table 66. Pharmacy Purchasing & Products Drug Formulary Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Pharmacy Purchasing & Products Drug Formulary Management Product Portfolio Table 68. Pharmacy Purchasing & Products Recent Development Table 69. VativoRx Company Information Table 70. VativoRx Business Overview Table 71. VativoRx Drug Formulary Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. VativoRx Drug Formulary Management Product Portfolio Table 73. VativoRx Recent Development Table 74. Nuwae Company Information Table 75. Nuwae Business Overview Table 76. Nuwae Drug Formulary Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Nuwae Drug Formulary Management Product Portfolio Table 78. Nuwae Recent Development Table 79. MedReb8 Company Information Table 80. MedReb8 Business Overview Table 81. MedReb8 Drug Formulary Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. MedReb8 Drug Formulary Management Product Portfolio Table 83. MedReb8 Recent Development Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Drug Formulary Management Product Image Figure 2. Global Drug Formulary Management Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Formulary Management Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Formulary Management Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Open Formulary Image Figure 8. Closed Formulary Image Figure 9. Global Drug Formulary Management Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Drug Formulary Management Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Drug Formulary Management Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Managed Care Organization (MCO) Image Figure 14. Others Image Figure 15. Global Drug Formulary Management Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Drug Formulary Management Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Drug Formulary Management Sales Value Share by Application (2021-2032) Figure 18. Global Drug Formulary Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Drug Formulary Management Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Drug Formulary Management Sales Value (2021-2032) & (US$ Million) Figure 21. North America Drug Formulary Management Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Drug Formulary Management Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Drug Formulary Management Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Drug Formulary Management Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Drug Formulary Management Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Drug Formulary Management Sales Value (2021-2032) & (US$ Million) Figure 27. South America Drug Formulary Management Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Drug Formulary Management Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Drug Formulary Management Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Drug Formulary Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Drug Formulary Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Drug Formulary Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Open Formulary
  • Closed Formulary
Applications
  • Hospital
  • Managed Care Organization (MCO)
  • Others
Companies covered
  • First Databank
  • Evernorth Health
  • Wolters Kluwer
  • McKesson
  • Salesforce
  • Pharmacy Purchasing & Products
  • VativoRx
  • Nuwae
  • MedReb8

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Formulary Management Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Formulary Management Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Drug Formulary Management Market Dynamics
  1. 2.1 Drug Formulary Management Industry Trends
  2. 2.2 Drug Formulary Management Industry Drivers
  3. 2.3 Drug Formulary Management Industry Opportunities and Challenges
  4. 2.4 Drug Formulary Management Industry Restraints
3 Drug Formulary Management Market by Company
  1. 3.1 Global Drug Formulary Management Company Revenue Ranking in 2025
  2. 3.2 Global Drug Formulary Management Revenue by Company (2021-2026)
  3. 3.3 Global Drug Formulary Management Company Ranking (2024-2026)
  4. 3.4 Global Drug Formulary Management Company Manufacturing Base and Headquarters
  5. 3.5 Global Drug Formulary Management Company Product Type and Application
  6. 3.6 Global Drug Formulary Management Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Drug Formulary Management Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Drug Formulary Management Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Drug Formulary Management Market by Type
  1. 4.1 Drug Formulary Management Type Introduction
  2. 4.1.1 Open Formulary
  3. 4.1.2 Closed Formulary
  4. 4.2 Global Drug Formulary Management Sales Value by Type
  5. 4.2.1 Global Drug Formulary Management Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Drug Formulary Management Sales Value by Type (2021-2032)
  7. 4.2.3 Global Drug Formulary Management Sales Value Share by Type (2021-2032)
5 Drug Formulary Management Market by Application
  1. 5.1 Drug Formulary Management Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Managed Care Organization (MCO)
  4. 5.1.3 Others
  5. 5.2 Global Drug Formulary Management Sales Value by Application
  6. 5.2.1 Global Drug Formulary Management Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug Formulary Management Sales Value by Application (2021-2032)
  8. 5.2.3 Global Drug Formulary Management Sales Value Share by Application (2021-2032)
6 Drug Formulary Management Regional Value Analysis
  1. 6.1 Global Drug Formulary Management Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Formulary Management Sales Value by Region (2021-2032)
  3. 6.2.1 Global Drug Formulary Management Sales Value by Region: 2021-2026
  4. 6.2.2 Global Drug Formulary Management Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Formulary Management Sales Value (2021-2032)
  7. 6.3.2 North America Drug Formulary Management Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Drug Formulary Management Sales Value (2021-2032)
  10. 6.4.2 Europe Drug Formulary Management Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Drug Formulary Management Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Drug Formulary Management Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Drug Formulary Management Sales Value (2021-2032)
  16. 6.6.2 South America Drug Formulary Management Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Drug Formulary Management Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Drug Formulary Management Sales Value Share by Country, 2025 VS 2032
7 Drug Formulary Management Country-level Value Analysis
  1. 7.1 Global Drug Formulary Management Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drug Formulary Management Sales Value by Country (2021-2032)
  3. 7.2.1 Global Drug Formulary Management Sales Value by Country (2021-2026)
  4. 7.2.2 Global Drug Formulary Management Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Drug Formulary Management Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Drug Formulary Management Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Drug Formulary Management Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Drug Formulary Management Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Drug Formulary Management Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Drug Formulary Management Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Drug Formulary Management Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Drug Formulary Management Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Drug Formulary Management Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Drug Formulary Management Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Drug Formulary Management Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Drug Formulary Management Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Drug Formulary Management Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Drug Formulary Management Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Drug Formulary Management Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Drug Formulary Management Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Drug Formulary Management Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Drug Formulary Management Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Drug Formulary Management Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Drug Formulary Management Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Drug Formulary Management Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Drug Formulary Management Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Drug Formulary Management Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Drug Formulary Management Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Drug Formulary Management Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Drug Formulary Management Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Drug Formulary Management Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Drug Formulary Management Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Drug Formulary Management Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Drug Formulary Management Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 First Databank
  2. 8.1.1 First Databank Company Information
  3. 8.1.2 First Databank Business Overview
  4. 8.1.3 First Databank Drug Formulary Management Revenue and Gross Margin (2021-2026)
  5. 8.1.4 First Databank Drug Formulary Management Product Portfolio
  6. 8.1.5 First Databank Recent Developments
  7. 8.2 Evernorth Health
  8. 8.2.1 Evernorth Health Company Information
  9. 8.2.2 Evernorth Health Business Overview
  10. 8.2.3 Evernorth Health Drug Formulary Management Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Evernorth Health Drug Formulary Management Product Portfolio
  12. 8.2.5 Evernorth Health Recent Developments
  13. 8.3 Wolters Kluwer
  14. 8.3.1 Wolters Kluwer Company Information
  15. 8.3.2 Wolters Kluwer Business Overview
  16. 8.3.3 Wolters Kluwer Drug Formulary Management Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wolters Kluwer Drug Formulary Management Product Portfolio
  18. 8.3.5 Wolters Kluwer Recent Developments
  19. 8.4 McKesson
  20. 8.4.1 McKesson Company Information
  21. 8.4.2 McKesson Business Overview
  22. 8.4.3 McKesson Drug Formulary Management Revenue and Gross Margin (2021-2026)
  23. 8.4.4 McKesson Drug Formulary Management Product Portfolio
  24. 8.4.5 McKesson Recent Developments
  25. 8.5 Salesforce
  26. 8.5.1 Salesforce Company Information
  27. 8.5.2 Salesforce Business Overview
  28. 8.5.3 Salesforce Drug Formulary Management Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Salesforce Drug Formulary Management Product Portfolio
  30. 8.5.5 Salesforce Recent Developments
  31. 8.6 Pharmacy Purchasing & Products
  32. 8.6.1 Pharmacy Purchasing & Products Company Information
  33. 8.6.2 Pharmacy Purchasing & Products Business Overview
  34. 8.6.3 Pharmacy Purchasing & Products Drug Formulary Management Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pharmacy Purchasing & Products Drug Formulary Management Product Portfolio
  36. 8.6.5 Pharmacy Purchasing & Products Recent Developments
  37. 8.7 VativoRx
  38. 8.7.1 VativoRx Company Information
  39. 8.7.2 VativoRx Business Overview
  40. 8.7.3 VativoRx Drug Formulary Management Revenue and Gross Margin (2021-2026)
  41. 8.7.4 VativoRx Drug Formulary Management Product Portfolio
  42. 8.7.5 VativoRx Recent Developments
  43. 8.8 Nuwae
  44. 8.8.1 Nuwae Company Information
  45. 8.8.2 Nuwae Business Overview
  46. 8.8.3 Nuwae Drug Formulary Management Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nuwae Drug Formulary Management Product Portfolio
  48. 8.8.5 Nuwae Recent Developments
  49. 8.9 MedReb8
  50. 8.9.1 MedReb8 Company Information
  51. 8.9.2 MedReb8 Business Overview
  52. 8.9.3 MedReb8 Drug Formulary Management Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MedReb8 Drug Formulary Management Product Portfolio
  54. 8.9.5 MedReb8 Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst